(Q36390884)

13 August 2017

1 reference

title

Quality of life for patients with epilepsy is determined by more than seizure control: the role of psychosocial factors (English)

1 reference

13 August 2017

1 reference

1 reference

Steven C Schachter

1

1 reference

13 August 2017

publication date

1 January 2006

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

13 August 2017

published in

1 reference

13 August 2017

volume

6

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

111-118

1 reference

Epilepsy from the Patient's Perspective: Review of Results of a Community-Based Survey

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Total patient care in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Advances in the assessment of refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Seizure reduction and quality of life improvements in people with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

The relationship between seizure frequency, seizure type and quality of life: findings from three European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Quality of life of people with epilepsy: a European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Psychosocial issues in people with epilepsy in Togo and Benin (West Africa) II: quality of life measured using the QOLIE-31 scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Injury and death as a result of seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Sudden unexplained death among subjects with refractory epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

The efficacy of an educational treatment program for patients with epilepsy (MOSES): results of a controlled, randomized study. Modular Service Package Epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Quality of life after epilepsy surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Quality of life in patients with epilepsy and impact of treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Antiepileptic drugs and the regulation of mood and quality of life (QOL): the evidence from epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Mood effects of antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Improvement in seizure control and quality of life in medically refractory epilepsy patients converted from polypharmacy to monotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Quality of life in pediatric epilepsy: demographic and disease-related predictors and comparison with healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Extended-release formulations: simplifying strategies in the management of antiepileptic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Quality-of-life and behavioral outcome measures in randomized controlled trials of antiepileptic drugs: a systematic review of methodology and reporting standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Medical comorbidities in the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Sleep disturbances, socioeconomic status, and seizure control as main predictors of quality of life in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Seizure disorders, depression, and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Subjective sleep disturbance in patients with partial epilepsy: a questionnaire-based study on prevalence and impact on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Evaluating health-related quality of life outcomes in clinical trials of antiepileptic drug therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Comparison of the psychometric characteristics of three quality of life measures in intractable epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

The initial development of a health-related quality of life model as an outcome measure in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

An objective method for the assessment of psychological and social problems among epileptics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Patient-validated content of epilepsy-specific quality-of-life measurement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Dimensions of the epilepsy foundation concerns index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Cognitive-behavioral group treatment program for adults with epilepsy in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Improved mood states with lamotrigine in patients with epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Maintenance of improvement in health-related quality of life during long-term treatment with levetiracetam

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Quality-of-Life Assessment in Patients Treated with Vagus Nerve Stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Changes in quality of life and self-perspective related to surgery in patients with temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Psychiatric morbidity, quality of life, and disability in mesial temporal lobe epilepsy patients before and after anterior temporal lobectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Epilepsy surgery: patient-perceived long-term costs and benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Effects of epilepsy surgery on quality of life: a controlled study in a Middle Eastern population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Psychosocial Well-Being of Carers of People with Epilepsy in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

The impact of mood disorders in neurological diseases: should neurologists be concerned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Mood disorders in patients with epilepsy: epidemiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Treatment of depressive disorders in epilepsy patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Video EEG monitoring prior to vagal nerve stimulator implantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Development of the quality of life in epilepsy inventory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Determinants of quality of life in epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

What is effective treatment of depression in people with epilepsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Pharmacotherapy of Mood Disorders in Epilepsy: The Role of Newer Psychotropic Drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

21 January 2018

Epilepsy and anxiety.

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Anxiety in patients with epilepsy: systematic review and suggestions for clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

21 January 2018

Epilepsy and Anxiety.

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Paradoxical results in the cure of chronic illness: the "burden of normality" as exemplified following seizure surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Differentiating anxiety and depression symptoms in patients with partial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Impact of a seizure disorder disease management program on patient-reported quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Taking charge of epilepsy: the development of a structured psychoeducational group intervention for adolescents with epilepsy and their parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Parental anxiety and quality of life in children with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Impact of the Children's Epilepsy Program on parents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Stigma in the lives of adolescents with epilepsy: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Treatments and perceptions of epilepsy in Kashmir and the United States: a cross-cultural analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Epilepsy and insurance in the UK: an exploratory survey of the experiences of people with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Overview and perspectives of employment in people with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Self-efficacy and social support as mediators in the relation between disease severity and quality of life in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

The impact of affectivity dispositions, self-efficacy and locus of control on psychosocial adjustment in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Project EASE: a study to test a psychosocial model of epilepsy medication managment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

A structured, nurse-led intervention program improves quality of life in patients with epilepsy: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Achieving best care for women with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

Quality of life in the elderly with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

The Treatment Gap in Epilepsy: The Current Situation and Ways Forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.6.1.111

21 January 2018

Identifiers

DOI

10.1586/14737175.6.1.111

1 reference

13 August 2017

1 reference